Assoc. Prof. Dr. Yanmiao Ma, Shanxi University of Traditional Chinese Medicine, China.
🔬 Dr. Yanmiao Ma is a distinguished researcher specializing in biomedical engineering and materials science. With a strong focus on nanomaterials 🧪 and drug delivery systems 💊, Dr. Ma has contributed significantly to biomedical advancements. His has authored numerous high-impact publications 📖 and received prestigious research awards 🏆. Passionate about innovation and interdisciplinary collaboration 🤝, his continues to push the boundaries of medical technology. His work is shaping the future of healthcare solutions 🏥.
Professional Profile
🎓 Early Academic Pursuits
Yanmiao Ma embarked on a distinguished academic journey in Traditional Chinese Medicine (TCM), laying a strong foundation with a B.S. in Clinical Traditional Chinese Medicine from Shanxi College of Traditional Chinese Medicine (2002–2007).His further honed his expertise by earning an M.S. in Traditional Chinese Medicine from Shanxi Institute of Traditional Chinese Medicine (2007–2010).His pursuit of excellence culminated in a Ph.D. in Basic Medical Sciences from Hubei University of Chinese Medicine (2010–2013), where his focused on the mechanisms underlying TCM treatments for autoimmune diseases
💼 Professional Endeavors
Dr. Ma’s career is marked by significant academic and research contributions. His currently serves as an Associate Professor at the School of Basic Medical Sciences, Shanxi University of Chinese Medicine (2017–Present).His dedication to advancing biomedical research led his to a Visiting Scholar position at the School of Life Sciences, Shaanxi Normal University (2021–2022), specializing in Bioinformatics. Additionally,his participated in training programs under the Ministry of Education, focusing on English teaching for international students (2018). Previously,His contributed as a Lecturer at Shanxi University of Chinese Medicine (2013–2017).
🔬 Contributions and Research Focus On Molecular Biology
Dr. Ma’s research spans multiple domains of rheumatology, immunology, gut microbiota, and cancer immunology.His work explores the mechanisms of TCM in treating rheumatoid arthritis (RA), particularly through immune regulation and synovial apoptosis, emphasizing the JAK-STAT/NF-κB signaling pathways.His is actively investigating the gut-joint axis in autoimmune diseases and pioneering fecal microbiota transplantation (FMT) for RA therapy.His contributions to cancer immunology focus on breast cancer stem cells, epithelial-mesenchymal transition (EMT), and lncRNA/miRNA regulatory networks, integrating TCM compounds such as icariin and ephedra polysaccharides into tumor microenvironment modulation.
🌍 Impact and Influence
Dr. Ma’s research has significantly advanced the understanding of TCM’s role in modern medicine.His studies on gut microbiota, autoimmune diseases, and cancer biology have influenced clinical applications and innovative therapeutic approaches.His has been at the forefront of developing multimodal studies, integrating TCM formulations with advanced biomedical research.His work has led to novel insights into microbial metabolites, immune modulation, and TCM-based drug delivery systems, fostering cross-disciplinary collaboration between traditional and modern medicine.
🏆 Awards and Honors
Dr. Ma has been the recipient of numerous prestigious research grants and awards, including:
- Shanxi University of Chinese Medicine Basic-Clinical Collaboration Project (2024–2026)
- Shanxi Provincial Science Foundation General Project (2024–2027)
- Shanxi Health Commission TCM Innovation Team Leadership (2024–2027)
- NSFC Youth Program for groundbreaking research on gut microbiota and rheumatoid arthritis (2022–2024)
Her contributions have been acknowledged through his leadership in multiple high-impact projects, securing significant research funding.
📚 Academic Citations
Dr. Ma has published extensively in high-impact journals, withHis research frequently cited in the fields of pharmacology, immunology, and biomedical sciences.His notable publications include studies on Ephedra sinica polysaccharides and rheumatoid arthritis, Icariin’s role in breast cancer EMT, and a scientometric analysis of kidney disease and gut microbiota.His research has received international recognition, positioning his as a leading figure in TCM-related biomedical studies.
📚Publications Top Notes
“Ephedra sinica polysaccharides regulate the anti-inflammatory immunity of intestinal microecology and bacterial metabolites in rheumatoid arthritis. Frontiers in Pharmacology”
“Icariin regulates EMT and stem cell-like character in breast cancer through modulating lncRNA NEAT1/TGFβ/SMAD2 signaling pathway.Biological and Pharmaceutical Bulletin”
“Preparation and biocompatibility of demineralized bone matrix/sodium alginate putty”
“Efficacy of Posterior Fossa Decompression with Duraplasty for Patients with Chiari Malformation Type I: A Systematic Review and Meta- Analysis“